Goldman Sachs’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-157,592
| Closed | -$728K | – | 4381 |
|
2019
Q1 | $728K | Buy |
157,592
+10,688
| +7% | +$49.4K | ﹤0.01% | 3405 |
|
2018
Q4 | $514K | Sell |
146,904
-722
| -0.5% | -$2.53K | ﹤0.01% | 3399 |
|
2018
Q3 | $1.49M | Buy |
147,626
+3,432
| +2% | +$34.6K | ﹤0.01% | 3004 |
|
2018
Q2 | $1.04M | Buy |
144,194
+27,241
| +23% | +$197K | ﹤0.01% | 3177 |
|
2018
Q1 | $706K | Sell |
116,953
-723
| -0.6% | -$4.36K | ﹤0.01% | 3336 |
|
2017
Q4 | $1.13M | Sell |
117,676
-16,163
| -12% | -$155K | ﹤0.01% | 3101 |
|
2017
Q3 | $1.19M | Sell |
133,839
-3,614
| -3% | -$32.1K | ﹤0.01% | 3140 |
|
2017
Q2 | $1.74M | Sell |
137,453
-89,115
| -39% | -$1.13M | ﹤0.01% | 2872 |
|
2017
Q1 | $2.38M | Sell |
226,568
-39,168
| -15% | -$412K | ﹤0.01% | 2619 |
|
2016
Q4 | $2.45M | Buy |
265,736
+78,476
| +42% | +$722K | ﹤0.01% | 2593 |
|
2016
Q3 | $2.21M | Sell |
187,260
-466,877
| -71% | -$5.5M | ﹤0.01% | 2653 |
|
2016
Q2 | $8.46M | Buy |
654,137
+408,606
| +166% | +$5.29M | ﹤0.01% | 1852 |
|
2016
Q1 | $3.93M | Sell |
245,531
-119,503
| -33% | -$1.91M | ﹤0.01% | 2190 |
|
2015
Q4 | $10.5M | Sell |
365,034
-349,812
| -49% | -$10M | ﹤0.01% | 1661 |
|
2015
Q3 | $20.3M | Buy |
714,846
+644,557
| +917% | +$18.3M | 0.01% | 1273 |
|
2015
Q2 | $2.53M | Buy |
70,289
+33,893
| +93% | +$1.22M | ﹤0.01% | 2445 |
|
2015
Q1 | $1.06M | Sell |
36,396
-91,186
| -71% | -$2.65M | ﹤0.01% | 2874 |
|
2014
Q4 | $2.69M | Sell |
127,582
-212,144
| -62% | -$4.47M | ﹤0.01% | 2333 |
|
2014
Q3 | $6.59M | Buy |
339,726
+62,864
| +23% | +$1.22M | ﹤0.01% | 1824 |
|
2014
Q2 | $4.32M | Buy |
276,862
+197,980
| +251% | +$3.09M | ﹤0.01% | 2096 |
|
2014
Q1 | $1.63M | Sell |
78,882
-456
| -0.6% | -$9.45K | ﹤0.01% | 2668 |
|
2013
Q4 | $1.02M | Buy |
+79,338
| New | +$1.02M | ﹤0.01% | 3056 |
|